The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Hemostatic Gel Market Research Report 2025
Synopsis
Hemostatic gel is used as an adjunct or alternative to standard suture techniques to control bleeding or wound closure.In recent years, global hemostatic gels have developed rapidly, with an average growth rate of around 7%.In 2018, global production of hemostatic gels was about 3.26 million pieces.In 2018, China accounted for about 3 percent of global sales.In the next five years, China's hemostatic gel products will continue to grow rapidly.Hemostatic gels are mainly divided into fibrin, gelatin and others, among which fibrin accounts for the largest proportion, accounting for nearly 38% of the total market in 2018, while gelatin accounts for 28%.Hemostatic gels are mainly used in minimally invasive surgery, general surgery and other aspects, among which minimally invasive surgery is the main application field, accounting for 51% in 2018 and general surgery for 28%.Hemostatic gels are mainly divided into fibrin, gelatin and others, among which fibrin accounts for the largest proportion, accounting for nearly 38% of the total market in 2018, while gelatin accounts for 28%.Hemostatic gels are mainly used in minimally invasive surgery, general surgery and other aspects, among which minimally invasive surgery is the main application field, accounting for 51% in 2018 and general surgery for 28%.Baxter, J&J, CryoLife, Integra Life Sciences are major suppliers.These suppliers have mastered key technologies and patents, and have a fixed customer base, which has formed a monopoly situation in the market.The growth of the elderly population and the increasing prevalence of chronic diseases are the driving factors affecting the industry.More than 45 percent of americans have at least one chronic condition that requires intensive care, according to the CDC.Elderly patients require intensive care, are prone to injury and take a long time to heal.Chronic diseases eventually led to surgery, which in turn spurred the development of the hemostatic gel industry.
The global Hemostatic Gel market was valued at US$ 947.3 million in 2023 and is anticipated to reach US$ 1356.5 million by 2030, witnessing a CAGR of 5.2% during the forecast period 2024-2030.
Global Hemostatic Gel key players include Baxter, J&J, Advance Medical Solution, etc. Global top three manufacturers hold a share over 45%.
North America is the largest market, with a share over 60%, followed by Europe, with a share over 20 percent.
In terms of product, Fibrin is the largest segment, with a share over 35%. And in terms of application, the largest application is Minimally Invasive Surgery, followed by General Surgery, etc.
This report aims to provide a comprehensive presentation of the global market for Hemostatic Gel, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hemostatic Gel.
Report Scope
The Hemostatic Gel market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Hemostatic Gel market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hemostatic Gel manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Baxter
J&J
CryoLife
Integra Life Sciences
Advance Medical Solution
BD
CSL Behring
Pfizer
B Braun
Segment by Type
Fibrin
Gelatin
Other
Segment by Application
Minimally Invasive Surgery
General Surgery
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Hemostatic Gel manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Hemostatic Gel in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Hemostatic gel is used as an adjunct or alternative to standard suture techniques to control bleeding or wound closure.In recent years, global hemostatic gels have developed rapidly, with an average growth rate of around 7%.In 2018, global production of hemostatic gels was about 3.26 million pieces.In 2018, China accounted for about 3 percent of global sales.In the next five years, China's hemostatic gel products will continue to grow rapidly.Hemostatic gels are mainly divided into fibrin, gelatin and others, among which fibrin accounts for the largest proportion, accounting for nearly 38% of the total market in 2018, while gelatin accounts for 28%.Hemostatic gels are mainly used in minimally invasive surgery, general surgery and other aspects, among which minimally invasive surgery is the main application field, accounting for 51% in 2018 and general surgery for 28%.Hemostatic gels are mainly divided into fibrin, gelatin and others, among which fibrin accounts for the largest proportion, accounting for nearly 38% of the total market in 2018, while gelatin accounts for 28%.Hemostatic gels are mainly used in minimally invasive surgery, general surgery and other aspects, among which minimally invasive surgery is the main application field, accounting for 51% in 2018 and general surgery for 28%.Baxter, J&J, CryoLife, Integra Life Sciences are major suppliers.These suppliers have mastered key technologies and patents, and have a fixed customer base, which has formed a monopoly situation in the market.The growth of the elderly population and the increasing prevalence of chronic diseases are the driving factors affecting the industry.More than 45 percent of americans have at least one chronic condition that requires intensive care, according to the CDC.Elderly patients require intensive care, are prone to injury and take a long time to heal.Chronic diseases eventually led to surgery, which in turn spurred the development of the hemostatic gel industry.
The global Hemostatic Gel market was valued at US$ 947.3 million in 2023 and is anticipated to reach US$ 1356.5 million by 2030, witnessing a CAGR of 5.2% during the forecast period 2024-2030.
Global Hemostatic Gel key players include Baxter, J&J, Advance Medical Solution, etc. Global top three manufacturers hold a share over 45%.
North America is the largest market, with a share over 60%, followed by Europe, with a share over 20 percent.
In terms of product, Fibrin is the largest segment, with a share over 35%. And in terms of application, the largest application is Minimally Invasive Surgery, followed by General Surgery, etc.
This report aims to provide a comprehensive presentation of the global market for Hemostatic Gel, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hemostatic Gel.
Report Scope
The Hemostatic Gel market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Hemostatic Gel market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hemostatic Gel manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Baxter
J&J
CryoLife
Integra Life Sciences
Advance Medical Solution
BD
CSL Behring
Pfizer
B Braun
Segment by Type
Fibrin
Gelatin
Other
Segment by Application
Minimally Invasive Surgery
General Surgery
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Hemostatic Gel manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Hemostatic Gel in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Hemostatic Gel Market Overview
1.1 Product Overview and Scope of Hemostatic Gel
1.2 Hemostatic Gel Segment by Type
1.2.1 Global Hemostatic Gel Market Value Comparison by Type (2024-2030)
1.2.2 Fibrin
1.2.3 Gelatin
1.2.4 Other
1.3 Hemostatic Gel Segment by Application
1.3.1 Global Hemostatic Gel Market Value by Application: (2024-2030)
1.3.2 Minimally Invasive Surgery
1.3.3 General Surgery
1.3.4 Others
1.4 Global Hemostatic Gel Market Size Estimates and Forecasts
1.4.1 Global Hemostatic Gel Revenue 2019-2030
1.4.2 Global Hemostatic Gel Sales 2019-2030
1.4.3 Global Hemostatic Gel Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Hemostatic Gel Market Competition by Manufacturers
2.1 Global Hemostatic Gel Sales Market Share by Manufacturers (2019-2024)
2.2 Global Hemostatic Gel Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Hemostatic Gel Average Price by Manufacturers (2019-2024)
2.4 Global Hemostatic Gel Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Hemostatic Gel, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Hemostatic Gel, Product Type & Application
2.7 Hemostatic Gel Market Competitive Situation and Trends
2.7.1 Hemostatic Gel Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Hemostatic Gel Players Market Share by Revenue
2.7.3 Global Hemostatic Gel Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Hemostatic Gel Retrospective Market Scenario by Region
3.1 Global Hemostatic Gel Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Hemostatic Gel Global Hemostatic Gel Sales by Region: 2019-2030
3.2.1 Global Hemostatic Gel Sales by Region: 2019-2024
3.2.2 Global Hemostatic Gel Sales by Region: 2025-2030
3.3 Global Hemostatic Gel Global Hemostatic Gel Revenue by Region: 2019-2030
3.3.1 Global Hemostatic Gel Revenue by Region: 2019-2024
3.3.2 Global Hemostatic Gel Revenue by Region: 2025-2030
3.4 North America Hemostatic Gel Market Facts & Figures by Country
3.4.1 North America Hemostatic Gel Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Hemostatic Gel Sales by Country (2019-2030)
3.4.3 North America Hemostatic Gel Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Hemostatic Gel Market Facts & Figures by Country
3.5.1 Europe Hemostatic Gel Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Hemostatic Gel Sales by Country (2019-2030)
3.5.3 Europe Hemostatic Gel Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Hemostatic Gel Market Facts & Figures by Country
3.6.1 Asia Pacific Hemostatic Gel Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Hemostatic Gel Sales by Country (2019-2030)
3.6.3 Asia Pacific Hemostatic Gel Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Hemostatic Gel Market Facts & Figures by Country
3.7.1 Latin America Hemostatic Gel Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Hemostatic Gel Sales by Country (2019-2030)
3.7.3 Latin America Hemostatic Gel Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Hemostatic Gel Market Facts & Figures by Country
3.8.1 Middle East and Africa Hemostatic Gel Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Hemostatic Gel Sales by Country (2019-2030)
3.8.3 Middle East and Africa Hemostatic Gel Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Hemostatic Gel Sales by Type (2019-2030)
4.1.1 Global Hemostatic Gel Sales by Type (2019-2024)
4.1.2 Global Hemostatic Gel Sales by Type (2025-2030)
4.1.3 Global Hemostatic Gel Sales Market Share by Type (2019-2030)
4.2 Global Hemostatic Gel Revenue by Type (2019-2030)
4.2.1 Global Hemostatic Gel Revenue by Type (2019-2024)
4.2.2 Global Hemostatic Gel Revenue by Type (2025-2030)
4.2.3 Global Hemostatic Gel Revenue Market Share by Type (2019-2030)
4.3 Global Hemostatic Gel Price by Type (2019-2030)
5 Segment by Application
5.1 Global Hemostatic Gel Sales by Application (2019-2030)
5.1.1 Global Hemostatic Gel Sales by Application (2019-2024)
5.1.2 Global Hemostatic Gel Sales by Application (2025-2030)
5.1.3 Global Hemostatic Gel Sales Market Share by Application (2019-2030)
5.2 Global Hemostatic Gel Revenue by Application (2019-2030)
5.2.1 Global Hemostatic Gel Revenue by Application (2019-2024)
5.2.2 Global Hemostatic Gel Revenue by Application (2025-2030)
5.2.3 Global Hemostatic Gel Revenue Market Share by Application (2019-2030)
5.3 Global Hemostatic Gel Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Baxter
6.1.1 Baxter Corporation Information
6.1.2 Baxter Description and Business Overview
6.1.3 Baxter Hemostatic Gel Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Baxter Hemostatic Gel Product Portfolio
6.1.5 Baxter Recent Developments/Updates
6.2 J&J
6.2.1 J&J Corporation Information
6.2.2 J&J Description and Business Overview
6.2.3 J&J Hemostatic Gel Sales, Revenue and Gross Margin (2019-2024)
6.2.4 J&J Hemostatic Gel Product Portfolio
6.2.5 J&J Recent Developments/Updates
6.3 CryoLife
6.3.1 CryoLife Corporation Information
6.3.2 CryoLife Description and Business Overview
6.3.3 CryoLife Hemostatic Gel Sales, Revenue and Gross Margin (2019-2024)
6.3.4 CryoLife Hemostatic Gel Product Portfolio
6.3.5 CryoLife Recent Developments/Updates
6.4 Integra Life Sciences
6.4.1 Integra Life Sciences Corporation Information
6.4.2 Integra Life Sciences Description and Business Overview
6.4.3 Integra Life Sciences Hemostatic Gel Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Integra Life Sciences Hemostatic Gel Product Portfolio
6.4.5 Integra Life Sciences Recent Developments/Updates
6.5 Advance Medical Solution
6.5.1 Advance Medical Solution Corporation Information
6.5.2 Advance Medical Solution Description and Business Overview
6.5.3 Advance Medical Solution Hemostatic Gel Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Advance Medical Solution Hemostatic Gel Product Portfolio
6.5.5 Advance Medical Solution Recent Developments/Updates
6.6 BD
6.6.1 BD Corporation Information
6.6.2 BD Description and Business Overview
6.6.3 BD Hemostatic Gel Sales, Revenue and Gross Margin (2019-2024)
6.6.4 BD Hemostatic Gel Product Portfolio
6.6.5 BD Recent Developments/Updates
6.7 CSL Behring
6.6.1 CSL Behring Corporation Information
6.6.2 CSL Behring Description and Business Overview
6.6.3 CSL Behring Hemostatic Gel Sales, Revenue and Gross Margin (2019-2024)
6.4.4 CSL Behring Hemostatic Gel Product Portfolio
6.7.5 CSL Behring Recent Developments/Updates
6.8 Pfizer
6.8.1 Pfizer Corporation Information
6.8.2 Pfizer Description and Business Overview
6.8.3 Pfizer Hemostatic Gel Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Pfizer Hemostatic Gel Product Portfolio
6.8.5 Pfizer Recent Developments/Updates
6.9 B Braun
6.9.1 B Braun Corporation Information
6.9.2 B Braun Description and Business Overview
6.9.3 B Braun Hemostatic Gel Sales, Revenue and Gross Margin (2019-2024)
6.9.4 B Braun Hemostatic Gel Product Portfolio
6.9.5 B Braun Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Hemostatic Gel Industry Chain Analysis
7.2 Hemostatic Gel Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Hemostatic Gel Production Mode & Process
7.4 Hemostatic Gel Sales and Marketing
7.4.1 Hemostatic Gel Sales Channels
7.4.2 Hemostatic Gel Distributors
7.5 Hemostatic Gel Customers
8 Hemostatic Gel Market Dynamics
8.1 Hemostatic Gel Industry Trends
8.2 Hemostatic Gel Market Drivers
8.3 Hemostatic Gel Market Challenges
8.4 Hemostatic Gel Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Hemostatic Gel Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Hemostatic Gel Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Hemostatic Gel Market Competitive Situation by Manufacturers in 2023
Table 4. Global Hemostatic Gel Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Hemostatic Gel Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Hemostatic Gel Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Hemostatic Gel Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Hemostatic Gel Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Hemostatic Gel, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Hemostatic Gel, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Hemostatic Gel, Product Type & Application
Table 12. Global Key Manufacturers of Hemostatic Gel, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Hemostatic Gel by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hemostatic Gel as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Hemostatic Gel Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Hemostatic Gel Sales by Region (2019-2024) & (K Units)
Table 18. Global Hemostatic Gel Sales Market Share by Region (2019-2024)
Table 19. Global Hemostatic Gel Sales by Region (2025-2030) & (K Units)
Table 20. Global Hemostatic Gel Sales Market Share by Region (2025-2030)
Table 21. Global Hemostatic Gel Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Hemostatic Gel Revenue Market Share by Region (2019-2024)
Table 23. Global Hemostatic Gel Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Hemostatic Gel Revenue Market Share by Region (2025-2030)
Table 25. North America Hemostatic Gel Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Hemostatic Gel Sales by Country (2019-2024) & (K Units)
Table 27. North America Hemostatic Gel Sales by Country (2025-2030) & (K Units)
Table 28. North America Hemostatic Gel Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Hemostatic Gel Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Hemostatic Gel Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Hemostatic Gel Sales by Country (2019-2024) & (K Units)
Table 32. Europe Hemostatic Gel Sales by Country (2025-2030) & (K Units)
Table 33. Europe Hemostatic Gel Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Hemostatic Gel Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Hemostatic Gel Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Hemostatic Gel Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Hemostatic Gel Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Hemostatic Gel Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Hemostatic Gel Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Hemostatic Gel Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Hemostatic Gel Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Hemostatic Gel Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Hemostatic Gel Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Hemostatic Gel Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Hemostatic Gel Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Hemostatic Gel Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Hemostatic Gel Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Hemostatic Gel Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Hemostatic Gel Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Hemostatic Gel Sales (K Units) by Type (2019-2024)
Table 51. Global Hemostatic Gel Sales (K Units) by Type (2025-2030)
Table 52. Global Hemostatic Gel Sales Market Share by Type (2019-2024)
Table 53. Global Hemostatic Gel Sales Market Share by Type (2025-2030)
Table 54. Global Hemostatic Gel Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Hemostatic Gel Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Hemostatic Gel Revenue Market Share by Type (2019-2024)
Table 57. Global Hemostatic Gel Revenue Market Share by Type (2025-2030)
Table 58. Global Hemostatic Gel Price (US$/Unit) by Type (2019-2024)
Table 59. Global Hemostatic Gel Price (US$/Unit) by Type (2025-2030)
Table 60. Global Hemostatic Gel Sales (K Units) by Application (2019-2024)
Table 61. Global Hemostatic Gel Sales (K Units) by Application (2025-2030)
Table 62. Global Hemostatic Gel Sales Market Share by Application (2019-2024)
Table 63. Global Hemostatic Gel Sales Market Share by Application (2025-2030)
Table 64. Global Hemostatic Gel Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Hemostatic Gel Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Hemostatic Gel Revenue Market Share by Application (2019-2024)
Table 67. Global Hemostatic Gel Revenue Market Share by Application (2025-2030)
Table 68. Global Hemostatic Gel Price (US$/Unit) by Application (2019-2024)
Table 69. Global Hemostatic Gel Price (US$/Unit) by Application (2025-2030)
Table 70. Baxter Corporation Information
Table 71. Baxter Description and Business Overview
Table 72. Baxter Hemostatic Gel Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Baxter Hemostatic Gel Product
Table 74. Baxter Recent Developments/Updates
Table 75. J&J Corporation Information
Table 76. J&J Description and Business Overview
Table 77. J&J Hemostatic Gel Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. J&J Hemostatic Gel Product
Table 79. J&J Recent Developments/Updates
Table 80. CryoLife Corporation Information
Table 81. CryoLife Description and Business Overview
Table 82. CryoLife Hemostatic Gel Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. CryoLife Hemostatic Gel Product
Table 84. CryoLife Recent Developments/Updates
Table 85. Integra Life Sciences Corporation Information
Table 86. Integra Life Sciences Description and Business Overview
Table 87. Integra Life Sciences Hemostatic Gel Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Integra Life Sciences Hemostatic Gel Product
Table 89. Integra Life Sciences Recent Developments/Updates
Table 90. Advance Medical Solution Corporation Information
Table 91. Advance Medical Solution Description and Business Overview
Table 92. Advance Medical Solution Hemostatic Gel Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Advance Medical Solution Hemostatic Gel Product
Table 94. Advance Medical Solution Recent Developments/Updates
Table 95. BD Corporation Information
Table 96. BD Description and Business Overview
Table 97. BD Hemostatic Gel Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. BD Hemostatic Gel Product
Table 99. BD Recent Developments/Updates
Table 100. CSL Behring Corporation Information
Table 101. CSL Behring Description and Business Overview
Table 102. CSL Behring Hemostatic Gel Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. CSL Behring Hemostatic Gel Product
Table 104. CSL Behring Recent Developments/Updates
Table 105. Pfizer Corporation Information
Table 106. Pfizer Description and Business Overview
Table 107. Pfizer Hemostatic Gel Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Pfizer Hemostatic Gel Product
Table 109. Pfizer Recent Developments/Updates
Table 110. B Braun Corporation Information
Table 111. B Braun Description and Business Overview
Table 112. B Braun Hemostatic Gel Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. B Braun Hemostatic Gel Product
Table 114. B Braun Recent Developments/Updates
Table 115. Key Raw Materials Lists
Table 116. Raw Materials Key Suppliers Lists
Table 117. Hemostatic Gel Distributors List
Table 118. Hemostatic Gel Customers List
Table 119. Hemostatic Gel Market Trends
Table 120. Hemostatic Gel Market Drivers
Table 121. Hemostatic Gel Market Challenges
Table 122. Hemostatic Gel Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Hemostatic Gel
Figure 2. Global Hemostatic Gel Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Hemostatic Gel Market Share by Type in 2023 & 2030
Figure 4. Fibrin Product Picture
Figure 5. Gelatin Product Picture
Figure 6. Other Product Picture
Figure 7. Global Hemostatic Gel Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Hemostatic Gel Market Share by Application in 2023 & 2030
Figure 9. Minimally Invasive Surgery
Figure 10. General Surgery
Figure 11. Others
Figure 12. Global Hemostatic Gel Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Hemostatic Gel Market Size (2019-2030) & (US$ Million)
Figure 14. Global Hemostatic Gel Sales (2019-2030) & (K Units)
Figure 15. Global Hemostatic Gel Average Price (US$/Unit) & (2019-2030)
Figure 16. Hemostatic Gel Report Years Considered
Figure 17. Hemostatic Gel Sales Share by Manufacturers in 2023
Figure 18. Global Hemostatic Gel Revenue Share by Manufacturers in 2023
Figure 19. The Global 5 and 10 Largest Hemostatic Gel Players: Market Share by Revenue in 2023
Figure 20. Hemostatic Gel Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 21. Global Hemostatic Gel Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 22. North America Hemostatic Gel Sales Market Share by Country (2019-2030)
Figure 23. North America Hemostatic Gel Revenue Market Share by Country (2019-2030)
Figure 24. U.S. Hemostatic Gel Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Canada Hemostatic Gel Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Europe Hemostatic Gel Sales Market Share by Country (2019-2030)
Figure 27. Europe Hemostatic Gel Revenue Market Share by Country (2019-2030)
Figure 28. Germany Hemostatic Gel Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. France Hemostatic Gel Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. U.K. Hemostatic Gel Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Italy Hemostatic Gel Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Russia Hemostatic Gel Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Asia Pacific Hemostatic Gel Sales Market Share by Region (2019-2030)
Figure 34. Asia Pacific Hemostatic Gel Revenue Market Share by Region (2019-2030)
Figure 35. China Hemostatic Gel Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Japan Hemostatic Gel Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. South Korea Hemostatic Gel Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. India Hemostatic Gel Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Australia Hemostatic Gel Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. China Taiwan Hemostatic Gel Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Indonesia Hemostatic Gel Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Thailand Hemostatic Gel Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Malaysia Hemostatic Gel Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Latin America Hemostatic Gel Sales Market Share by Country (2019-2030)
Figure 45. Latin America Hemostatic Gel Revenue Market Share by Country (2019-2030)
Figure 46. Mexico Hemostatic Gel Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Brazil Hemostatic Gel Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Argentina Hemostatic Gel Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Middle East & Africa Hemostatic Gel Sales Market Share by Country (2019-2030)
Figure 50. Middle East & Africa Hemostatic Gel Revenue Market Share by Country (2019-2030)
Figure 51. Turkey Hemostatic Gel Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Saudi Arabia Hemostatic Gel Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. UAE Hemostatic Gel Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Global Sales Market Share of Hemostatic Gel by Type (2019-2030)
Figure 55. Global Revenue Market Share of Hemostatic Gel by Type (2019-2030)
Figure 56. Global Hemostatic Gel Price (US$/Unit) by Type (2019-2030)
Figure 57. Global Sales Market Share of Hemostatic Gel by Application (2019-2030)
Figure 58. Global Revenue Market Share of Hemostatic Gel by Application (2019-2030)
Figure 59. Global Hemostatic Gel Price (US$/Unit) by Application (2019-2030)
Figure 60. Hemostatic Gel Value Chain
Figure 61. Hemostatic Gel Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
